These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
875 related items for PubMed ID: 8137525
1. Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives. Sheu WH, Hsu CH, Chen YS, Jeng CY, Fuh MM. Clin Endocrinol (Oxf); 1994 Feb; 40(2):249-55. PubMed ID: 8137525 [Abstract] [Full Text] [Related]
2. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women. Straznicky NE, Barrington VE, Branley P, Louis WJ. J Hypertens; 1998 Mar; 16(3):357-68. PubMed ID: 9557929 [Abstract] [Full Text] [Related]
3. The short-term effects of a low-dose oral contraceptive on glucose metabolism, plasma lipids and blood clotting factors. Skouby SO, Wagner HH, Andersen O. Contraception; 1983 Nov; 28(5):489-99. PubMed ID: 6425010 [Abstract] [Full Text] [Related]
4. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V. N Engl J Med; 1990 Nov 15; 323(20):1375-81. PubMed ID: 2146499 [Abstract] [Full Text] [Related]
5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G. Int J Fertil Menopausal Stud; 1994 Nov 15; 39(5):283-91. PubMed ID: 7820162 [Abstract] [Full Text] [Related]
6. Glucose and lipid metabolism with triphasic oral contraceptives in women with history of gestational diabetes. Kung AW, Ma JT, Wong VC, Li DF, Ng MM, Wang CC, Lam KS, Young RT, Ma HK. Contraception; 1987 Mar 15; 35(3):257-69. PubMed ID: 3111786 [Abstract] [Full Text] [Related]
7. Long-term effects of the combined oral contraceptive pill on carbohydrate and lipid metabolism in Singapore women--a cross-sectional study. Ng CS, Chng JW, Oakley NW, Wynn V, Ratnam SS. Ann Acad Med Singap; 1982 Oct 15; 11(4):567-74. PubMed ID: 6762138 [Abstract] [Full Text] [Related]
8. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins. Crook D, Godsland IF, Worthington M, Felton CV, Proudler AJ, Stevenson JC. Am J Obstet Gynecol; 1993 Nov 15; 169(5):1183-9. PubMed ID: 8238183 [Abstract] [Full Text] [Related]
9. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome. Falsetti L, Pasinetti E. Acta Obstet Gynecol Scand; 1995 Jan 15; 74(1):56-60. PubMed ID: 7856434 [Abstract] [Full Text] [Related]
10. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus. Petersen KR. Dan Med Bull; 2002 Feb 15; 49(1):43-60. PubMed ID: 11894723 [Abstract] [Full Text] [Related]
11. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel. Fioretti P, Fruzzetti F, Navalesi R, Ricci C, Miccoli R, Cerri M, Orlandi MC, Melis GB. Contraception; 1987 Mar 15; 35(3):229-43. PubMed ID: 2956055 [Abstract] [Full Text] [Related]
12. Evaluation of a new triphasic oral contraceptive in private practice. Ellsworth HS, Ayerst RI, Harris JW, Stone RA, Anderson AE, Jones TL, Curtis MK. Contraception; 1986 Nov 15; 34(5):435-42. PubMed ID: 3102161 [Abstract] [Full Text] [Related]
13. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives. Oyelola OO. Contraception; 1993 May 15; 47(5):445-54. PubMed ID: 8513671 [Abstract] [Full Text] [Related]
14. The effects of two triphasic oral contraceptives on carbohydrate metabolism in women during 1 year of use. Spellacy WN, Ellingson AB, Tsibris JC. Fertil Steril; 1989 Jan 15; 51(1):71-4. PubMed ID: 2642814 [Abstract] [Full Text] [Related]
15. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. Oelkers W, Foidart JM, Dombrovicz N, Welter A, Heithecker R. J Clin Endocrinol Metab; 1995 Jun 15; 80(6):1816-21. PubMed ID: 7775629 [Abstract] [Full Text] [Related]
16. The metabolic impact of oral contraceptives. Krauss RM, Burkman RT. Am J Obstet Gynecol; 1992 Oct 15; 167(4 Pt 2):1177-84. PubMed ID: 1415443 [Abstract] [Full Text] [Related]
17. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins. Crook D, Godsland IF, Wynn V. Am J Obstet Gynecol; 1988 Jun 15; 158(6 Pt 2):1612-20. PubMed ID: 3287933 [Abstract] [Full Text] [Related]
18. Changes in insulin receptors during oral contraception. De Pirro R, Forte F, Bertoli A, Greco AV, Lauro R. J Clin Endocrinol Metab; 1981 Jan 15; 52(1):29-33. PubMed ID: 7451643 [Abstract] [Full Text] [Related]
19. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids. Petersen KR, Kjems LL, Skouby SO, Andersen LF, Jespersen J. Metabolism; 1996 Jul 15; 45(7):833-7. PubMed ID: 8692017 [Abstract] [Full Text] [Related]
20. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy. Lussier-Cacan S, Xhignesse M, Desmarais JL, Davignon J, Kafrissen ME, Chapdelaine A. Metabolism; 1991 Aug 15; 40(8):849-54. PubMed ID: 1907348 [Abstract] [Full Text] [Related] Page: [Next] [New Search]